Project Oncology®

187 Folgen

1. Exploring the Impacts of Race & Bias in Cancer Treatment

   Vom: 12.1.2021
2. Systemic Racism & Disparities in Oncology

   Vom: 12.1.2021
3. Assessing Advancements in Treatment Options for Small Cell Lung Cancer

   Vom: 6.1.2021
4. Exploring the Treatment Landscape for Head & Neck Cancer

   Vom: 23.12.2020
5. How COVID-19 Has Changed the Way We Approach Head & Neck Cancer Care

   Vom: 23.12.2020
6. The COVID-19 Pandemic & Dangerous Delays in Cancer Screenings

   Vom: 21.12.2020
7. HIPEC: A Novel Treatment for Advanced Abdominal Cancers

   Vom: 23.1.2020
8. Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines

   Vom: 12.7.2018
9. Not Quite a Cancer Vaccine: Selling HPV & Cervical Cancer

   Vom: 19.2.2018
10. What to Know About a State-of-the-Art Approach to GIST Treatment

    Vom: 17.1.2018
11. FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer

    Vom: 7.1.2018
12. CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer

    Vom: 23.10.2017
13. Pancreatic Cancer: The Hunt to Catch a Silent Killer

    Vom: 12.8.2017
14. FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer

    Vom: 28.7.2017
15. FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer

    Vom: 25.7.2017
16. Linking p53 Variation to Breast Cancer Risk in African American Women

    Vom: 19.6.2017
17. FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval

    Vom: 30.5.2017
18. Pancreatic Cancer: Associated Signs, Symptoms, Risk Factors and Treatment Approaches

    Vom: 23.5.2017
19. FDA D.I.S.C.O.: Avelumab in Merkel Cell Carcinoma

    Vom: 22.5.2017
20. FDA D.I.S.C.O.: Niraparib in Ovarian Cancer

    Vom: 18.5.2017